CME credits: 1.00

Valid until: 28-12-2023

Claim your CME credit at https://reachmd.com/programs/cme/innovative-therapeutic-approaches-in-hypertrophic-cardiomyopathy/14744/

Hypertrophic cardiomyopathy (HCM) is more than just a thickened heart. This series of three presentations provides insights into the etiology and pathogenesis of this complex disease, how to make the diagnosis, and the therapeutic options.

Dr. Antonis Pantazis starts his presentation off with a scientific definition of HCM and explains what distinguishes it from other conditions that feature a “thick heart.” Dr. Michelle Michels highlights the importance of a thorough work-up in patients with LV hypertrophy to make the correct diagnosis. Prof. Iacopo Olivotto discusses the study results of mavacamten, a drug specifically designed for treating HCM.

This course consists of the following:

• Chapter 1: Unhiding hypertrophic cardiomyopathy, a call for action - Antonis Pantazis, MD - London, UK
• Chapter 2: Hypertrophic cardiomyopathy: making the diagnosis - Michelle Michels, MD, PhD - Rotterdam, the Netherlands
• Chapter 3: Managing patients with hypertrophic cardiomyopathy: what is the therapeutic landscape? - Prof. Iacopo Olivotto, MD - Florence, Italy

=